Researchers with JangoBio, a Madison-based startup developing stem cell therapies, are set to begin testing on companion animals such as dogs within the next two months.
167800
post-template-default,single,single-post,postid-167800,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Researchers with JangoBio, a Madison-based startup developing stem cell therapies, are set to begin testing on companion animals such as dogs within the next two months.

JangoBio

Researchers with JangoBio, a Madison-based startup developing stem cell therapies, are set to begin testing on companion animals such as dogs within the next two months.

Bill Kohl, chief operating officer for JangoBio, says this marks a step forward in the company’s journey to bring its anti-aging therapy to market, starting with non-agricultural animals.

“Things look promising,” Kohl told WisBusiness.com. “We’re working on refining the application, increasing and improving efficacy, and of course monitoring for safety.”

JangoBio’s patent-pending therapy relies on stem cells to regrow certain tissues in the body that are responsible for maintaining healthy hormone levels. As people and animals age, these tissues degrade, leading to unbalanced hormones and a host of associated health problems.

READ FULL STORY